A novel two base pair deletion in the factor V gene associated with severe factor V deficiency

被引:34
作者
Montefusco, MC
Duga, S
Asselta, R
Santagostino, E
Mancuso, G
Malcovati, M
Mannucci, PM
Tenchini, ML
机构
[1] Univ Milan, Dept Biol & Genet Med Sci, I-20133 Milan, Italy
[2] Univ Milan, Angelo Bianchi Bonomi Haemophilia & Thrombosis Ct, I-20133 Milan, Italy
[3] Univ Milan, Fdn Luigi Villa, Dept Internal Med, I-20133 Milan, Italy
[4] IRCCS Maggiore Hosp, Milan, Italy
[5] Univ Palermo, Inst Paediat, I-90133 Palermo, Italy
关键词
inherited coagulation disorders; factor V deficiency; mutation; mRNA degradation;
D O I
10.1046/j.1365-2141.2000.02456.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied a family in which the proband, a 13-year-old boy, had unmeasurable plasma levels of coagulation factor V antigen and activity. Clinical symptoms were severe, with several episodes of haemorrhages in the mucosal tracts (gastrointestinal, nose and urinary) and recurrent haemarthroses that caused permanent arthropathy. Sequence analysis of the factor V gene demonstrated the presence of a novel 2 base pair (bp) homozygous deletion in exon 13 at positions 2833-2834. This mutation, present in the heterozygous state in the asymptomatic mother and absent in the healthy brother, introduced a frameshift and a premature stop at codon 900. This would predict the synthesis of a truncated factor V molecule, lacking part of the B domain and the complete light chain. Because of the existence of a surveillance mechanism that selectively recognizes and degrades mRNA molecules carrying premature termination codons, we analysed the relative abundance of mutant vs. wild-type mRNA molecules in the platelets of the heterozygous proband's mother. The mutant mRNA was significantly reduced in amount (mutant/wild-type ratio 0.35). This is the first reported mutation in the factor V gene causing severe factor V deficiency, the effect of which was quantitatively analysed at mRNA level.
引用
收藏
页码:1240 / 1246
页数:7
相关论文
共 32 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]   Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V leiden) and His1299Arg substitutions in factor V [J].
Castaman, G ;
Lunghi, B ;
Missiaglia, E ;
Bernardi, F ;
Rodeghiero, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :257-261
[3]   Molecular bases of pseudo-homozygous APC resistance: The compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma [J].
Castoldi, E ;
Kalafatis, M ;
Lunghi, B ;
Simioni, P ;
Ioannou, PA ;
Petio, M ;
Girolami, A ;
Mann, KG ;
Bernardi, F .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) :403-406
[4]   STRUCTURE OF THE GENE FOR HUMAN COAGULATION FACTOR-V [J].
CRIPE, LD ;
MOORE, KD ;
KANE, WH .
BIOCHEMISTRY, 1992, 31 (15) :3777-3785
[5]   Fatal haemorrhage and incomplete block to embryogenesis in mice locking coagulation factor V [J].
Cui, JS ;
OShea, KS ;
Purkayastha, A ;
Saunders, TL ;
Ginsburg, D .
NATURE, 1996, 384 (6604) :66-68
[6]  
FOSTER WB, 1983, J BIOL CHEM, V258, P3970
[7]   Nonsense-mediated mRNA decay in health and disease [J].
Frischmeyer, PA ;
Dietz, HC .
HUMAN MOLECULAR GENETICS, 1999, 8 (10) :1893-1900
[8]  
GEWIRTZ AM, 1986, BLOOD, V67, P1639
[9]   Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene [J].
Guasch, JF ;
Cannegieter, S ;
Reitsma, PH ;
Van't Veer-Korthof, ET ;
Bertina, RM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) :32-39
[10]  
Guasch JF, 1997, THROMB HAEMOSTASIS, V77, P252